It would be easier to wait patiently if we knew the company was testing AS (like it said it was going to do in Canada last year). The continued silence might tell us that the current quarter's 10Q is going to look like the last several quarters' 10Qs: nothing but hand-sitting going on here. Funds are running low again....no revenues from countries where AS has been approved. We inch closer to a mandatory shareholder meeting, an event really hampering my ability to wait patiently.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.